Precipio, Inc. (PRPO)
31.25
+0.13
(+0.42%)
USD |
NASDAQ |
Aug 25, 09:40
Precipio Enterprise Value : 56.19M for Aug. 24, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 56.19M |
| August 21, 2026 | 54.99M |
| August 20, 2026 | 53.17M |
| August 19, 2026 | 50.34M |
| August 18, 2026 | 44.69M |
| August 17, 2026 | 43.27M |
| August 14, 2026 | 42.56M |
| August 13, 2026 | 42.04M |
| August 12, 2026 | 40.84M |
| August 11, 2026 | 40.50M |
| August 10, 2026 | 40.95M |
| August 07, 2026 | 43.40M |
| August 06, 2026 | 42.49M |
| August 05, 2026 | 42.52M |
| August 04, 2026 | 41.22M |
| August 03, 2026 | 40.11M |
| July 31, 2026 | 39.25M |
| July 30, 2026 | 38.42M |
| July 29, 2026 | 39.60M |
| July 28, 2026 | 41.07M |
| July 27, 2026 | 41.52M |
| July 24, 2026 | 42.88M |
| July 23, 2026 | 41.45M |
| July 22, 2026 | 42.52M |
| July 21, 2026 | 42.91M |
| Date | Value |
|---|---|
| July 20, 2026 | 42.38M |
| July 17, 2026 | 44.60M |
| July 16, 2026 | 42.88M |
| July 15, 2026 | 45.67M |
| July 14, 2026 | 42.02M |
| July 13, 2026 | 43.45M |
| July 10, 2026 | 43.09M |
| July 09, 2026 | 47.89M |
| July 08, 2026 | 47.24M |
| July 07, 2026 | 47.03M |
| July 06, 2026 | 45.71M |
| July 02, 2026 | 45.71M |
| July 01, 2026 | 45.12M |
| June 30, 2026 | 44.81M |
| June 29, 2026 | 44.20M |
| June 26, 2026 | 42.47M |
| June 25, 2026 | 40.85M |
| June 24, 2026 | 41.84M |
| June 23, 2026 | 42.27M |
| June 22, 2026 | 42.35M |
| June 18, 2026 | 40.93M |
| June 17, 2026 | 40.77M |
| June 16, 2026 | 40.58M |
| June 15, 2026 | 40.91M |
| June 12, 2026 | 40.31M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| NeoGenomics, Inc. | 2.402B |
| Quest Diagnostics, Inc. | 32.97B |
| Labcorp Holdings, Inc. | 34.09B |
| OPKO Health, Inc. | 1.201B |
| Psychemedics Corp. | -- |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.219M |
| Revenue (Quarterly) | 7.021M |
| Total Expenses (Quarterly) | 7.24M |
| EPS Diluted (Quarterly) | -0.1225 |
| Gross Profit Margin (Quarterly) | 37.99% |
| Profit Margin (Quarterly) | -3.12% |
| Earnings Yield | -2.19% |
| Normalized Earnings Yield | -2.678 |